Auf dieser Seite
01BHC Preis
02Momentaufnahme
03Chart
04Aktiensplits
06Performance
07Bewertung & Kennzahlen
13Dividenden
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
23Nachrichten
26Meine Kennzahlen
BHC Bausch Health Companies Inc. Common Stock
NYSE · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Jul 30, 2026
$5,80
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$4,3352-Wochen-Tief
$8,0052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$2.17B
P/E (TTM)
-2.0
EPS (TTM)
$-2.96
Umsatz (TTM)
$10.85B
Ihre Abzeichen
52W-Spanne
$4–$8
Analystenbewertung
HOLD
Kursziel
$8
P/E
-2.0
ROE
86.6%
Nettogewinnmarge
-10.1%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
BHC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$5.80
Marktkapitalisierung (MRQ)
$2.17B
P/E (TTM)
-2.0
EPS (TTM)
$-2.96
Umsatz (TTM)
$10.85B
ROE (TTM)
86.6%
Verschuldungsgrad (MRQ)
-11.7
52W-Spanne
$4–$8
BHC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 16. Oktober 2000 | 2-for-1 | Vorwärts |
| 20. Januar 2000 | 2-for-1 | Vorwärts |
| 17. Januar 1996 | 3-for-1 | Vorwärts |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$10.27B2016-12-31 → 2025-12-31
EPS$0.422016-12-31 → 2025-12-31
Freier Cashflow$1.00B2016-12-31 → 2025-12-31
Nettogewinnmarge-10.1%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | BHC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -2.05-Jahres-Durchschnitt ≈-14.2 | ≈-14.2 | · | · | |
| P/S (TTM) | 0.25-Jahres-Durchschnitt ≈0.5 | ≈0.5 | · | · | |
| K/B (MRQ) | -1.25-Jahres-Durchschnitt ≈-21.3 | ≈-21.3 | · | · | |
| EV / EBITDA | 11.95-Jahres-Durchschnitt ≈34.6 | ≈34.6 | · | · | |
| Kurs / FCF (TTM) | 1.55-Jahres-Durchschnitt ≈2.9 | ≈2.9 | · | · | |
| Kurs / Cashflow (TTM) | 1.25-Jahres-Durchschnitt ≈2.1 | ≈2.1 | · | · | |
| EV / Revenue (EV / Umsatz) | 2.15-Jahres-Durchschnitt ≈2.8 | ≈2.8 | · | · | |
| EV / FCF | 21.65-Jahres-Durchschnitt ≈14.9 | ≈14.9 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | -0.4 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | BHC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 8.1%5-Jahres-Durchschnitt ≈11.1% | ≈11.1% | · | · | |
| EBITDA Margin (EBITDA-Marge) | 17.7%5-Jahres-Durchschnitt ≈11.1% | ≈11.1% | · | · | |
| Vorgewinnmarge (TTM) | -6.7%5-Jahres-Durchschnitt ≈-2.6% | ≈-2.6% | · | · | |
| Nettogewinnmarge (TTM) | -10.1%5-Jahres-Durchschnitt ≈-3.9% | ≈-3.9% | · | · | |
| ROA (TTM) | -4.2%5-Jahres-Durchschnitt ≈-1.2% | ≈-1.2% | · | · | |
| ROE (TTM) | 86.6%5-Jahres-Durchschnitt ≈-65.9% | ≈-65.9% | · | · | |
| ROIC | 2.9%5-Jahres-Durchschnitt ≈2.5% | ≈2.5% | · | · |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | BHC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | -11.75-Jahres-Durchschnitt ≈-64.0 | ≈-64.0 | · | · | |
| Liquiditätsgrad (MRQ) | 1.45-Jahres-Durchschnitt ≈1.2 | ≈1.2 | · | · | |
| Quick Ratio | 0.95-Jahres-Durchschnitt ≈0.6 | ≈0.6 | · | · | |
| Langfristige Schulden / Eigenkapital (MRQ) | -11.25-Jahres-Durchschnitt ≈-63.3 | ≈-63.3 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | BHC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 6.7%5-Jahres-Durchschnitt ≈5.2% | ≈5.2% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 8.1%5-Jahres-Durchschnitt ≈5.2% | ≈5.2% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 5.0% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | BHC | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.45-Jahres-Durchschnitt ≈0.3 | ≈0.3 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 4.65-Jahres-Durchschnitt ≈4.7 | ≈4.7 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$505.7K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Annualisierte Auszahlung≈$4.00
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Nov 10, 2010 | $1,00 | USD | ≈5.0% |
| Aug 30, 2010 | $0,10 | USD | ≈1.6% |
| Mai 28, 2010 | $0,10 | USD | ≈2.4% |
| Mär 4, 2010 | $0,09 | USD | ≈4.8% |
| Nov 30, 2009 | $0,09 | USD | ≈7.1% |
| Aug 28, 2009 | $0,09 | USD | ≈7.3% |
| Mai 13, 2009 | $0,09 | USD | ≈11.2% |
| Mär 6, 2009 | $0,38 | USD | ≈13.9% |
| Dez 19, 2008 | $0,38 | USD | ≈16.6% |
| Aug 21, 2008 | $0,38 | USD | ≈14.9% |
| Mai 20, 2008 | $0,38 | USD | ≈12.3% |
| Mär 25, 2008 | $0,38 | USD | ≈13.8% |
| Nov 16, 2007 | $0,38 | USD | ≈12.7% |
| Aug 16, 2007 | $0,38 | USD | ≈10.5% |
| Mai 18, 2007 | $0,38 | USD | ≈6.6% |
| Mär 22, 2007 | $0,38 | USD | ≈5.8% |
| Jan 8, 2007 | $0,50 | USD | ≈4.9% |
| Nov 20, 2006 | $0,13 | USD | ≈5.8% |
| Aug 16, 2006 | $0,13 | USD | ≈5.5% |
| Mai 19, 2006 | $0,13 | USD | ≈3.0% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-1.8%
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | $1.26 | $1.05 | 20.3% | |
| 31. März 2026 | $0.78 | $0.69 | 12.3% | |
| 31. Dezember 2025 | $1.10 | $1.28 | -13.9% | |
| 30. September 2025 | $1.16 | $1.13 | 2.6% | |
| 30. Juni 2025 | $0.91 | $0.98 | -7.1% | |
| 31. März 2025 | $0.60 | $0.80 | -25.1% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.27B | $9.62B | $8.76B | $8.12B | $8.43B | $8.03B | $8.60B | $8.38B | $8.72B | $9.67B | $10.45B | $8.21B | |
| Cost of Revenue | · | · | · | · | · | · | · | · | $2.51B | $2.57B | $2.53B | $2.18B | |
| SG&A Expense | $3.44B | $3.30B | $2.92B | $2.62B | $2.62B | $2.37B | $2.55B | $2.47B | $2.58B | $2.81B | $2.70B | $2.03B | |
| Operating Expenses | $8.45B | $8.08B | $7.79B | $7.67B | $7.98B | $7.35B | $8.80B | $10.76B | $8.62B | $10.24B | $8.92B | $6.21B | |
| Operating Income | $1.81B | $1.55B | $963M | $454M | $450M | $676M | $-203M | $-2.38B | $102M | $-566M | $1.53B | $2.00B | |
| Interest Income | $48M | $33M | $26M | $14M | $7M | $13M | $12M | $11M | $12M | $8M | $4M | $5M | |
| Other Non-op | $-142M | $-247M | $-28M | $-35M | $-373M | $-502M | $-1.43B | $20M | $348M | $-73M | $-295M | $263M | |
| Pretax Income | $367M | $167M | $-390M | $-129M | $-1.02B | $-934M | $-1.84B | $-4.15B | $-1.74B | $-2.44B | $-155M | $1.05B | |
| Income Tax | $247M | $239M | $221M | $83M | $-87M | $-375M | $-54M | $-10M | $-4.14B | $-27M | $133M | $174M | |
| Net Income | $157M | $-46M | $-592M | $-225M | $-948M | $-560M | $-1.79B | $-4.14B | $2.40B | $-2.41B | $-288M | $880M | |
| EPS (Basic) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | $-1.58 | $-5.08 | $-11.81 | $6.86 | $-6.94 | $-0.85 | $2.63 | |
| EPS (Diluted) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | $-1.58 | $-5.08 | $-11.81 | $6.83 | $-6.94 | $-0.85 | $2.58 | |
| Shares (Basic) | 370,900,000 | 368,000,000 | 364,900,000 | 362,000,000 | 358,900,000 | 355,000,000 | 352,100,000 | 351,300,000 | 350,200,000 | 347,300,000 | 342,700,000 | 335,400,000 | |
| Shares (Diluted) | 375,000,000 | 368,000,000 | 364,900,000 | 362,000,000 | 358,900,000 | 355,000,000 | 352,100,000 | 351,300,000 | 351,800,000 | 347,300,000 | 342,700,000 | 341,500,000 | |
| EBITDA | $1.81B | $1.55B | $963M | $454M | $450M | $676M | $-203M | $-2.38B | $102M | $-566M | $1.53B | $2.04B |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.31B | $1.18B | $947M | $564M | $582M | $605M | $3.24B | $721M | $720M | $542M | $597M | $323M | |
| Receivables | $2.35B | $2.14B | $2.00B | $1.79B | $1.77B | $1.58B | $1.84B | $1.86B | $2.13B | $2.52B | $2.69B | $2.08B | |
| Inventory | $1.63B | $1.59B | $1.54B | $1.09B | $993M | $1.09B | $1.11B | $934M | $1.05B | $1.06B | $1.26B | $889M | |
| Prepaid Expense | $852M | $838M | $1.09B | $776M | $720M | $855M | $779M | $689M | $771M | $696M | $963M | $651M | |
| Current Assets | $6.16B | $5.77B | $5.60B | $4.25B | $5.61B | $5.34B | $6.97B | $4.21B | $4.75B | $5.08B | $5.51B | $4.13B | |
| PP&E (Net) | $2.07B | $1.78B | $1.71B | $1.60B | $1.60B | $1.57B | $1.47B | $1.35B | $1.40B | $1.31B | $1.44B | $1.31B | |
| PP&E (Gross) | $4.50B | $3.92B | $3.79B | $3.52B | $3.42B | $3.35B | $3.11B | $2.88B | $2.83B | $2.51B | $2.63B | $2.29B | |
| Accum. Depreciation | $2.42B | $2.14B | $2.08B | $1.92B | $1.82B | $1.78B | $1.64B | $1.52B | $1.43B | $1.20B | $1.18B | $978M | |
| Goodwill | $11.27B | $11.09B | $11.18B | $11.55B | $12.46B | $13.04B | $13.13B | $13.14B | $15.59B | $15.79B | $18.55B | $9.36B | |
| Intangibles | $4.64B | $5.55B | $6.46B | $5.80B | $6.95B | $8.45B | $10.20B | $12.00B | $15.21B | $18.88B | $23.08B | $11.28B | |
| Other Non-current Assets | $378M | $363M | $307M | $326M | $340M | $664M | $411M | $109M | $111M | $184M | $224M | $167M | |
| Total Assets | $26.37B | $26.52B | $27.35B | $25.69B | $29.20B | $31.20B | $33.86B | $32.49B | $37.50B | $43.53B | $48.97B | $26.30B | |
| Accounts Payable | $600M | $589M | $719M | $521M | $407M | $337M | $503M | $411M | $365M | $324M | $434M | $398M | |
| Accrued Liabilities | $3.34B | $3.49B | $3.13B | $2.99B | $4.79B | $4.58B | $4.51B | $3.20B | $3.69B | $3.23B | $3.86B | $2.16B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $6M | $16M | $6M | |
| Current Liabilities | $4.18B | $6.75B | $4.30B | $3.94B | $5.20B | $4.91B | $6.25B | $3.84B | $4.27B | $3.61B | $5.31B | $2.71B | |
| Capital Leases | $167M | $165M | $148M | $184M | $214M | $227M | $240M | · | · | · | · | · | |
| Deferred Tax | $147M | $128M | $163M | $202M | $529M | $528M | $705M | $885M | $1.18B | $5.43B | $5.90B | $2.22B | |
| Other Non-current Liabilities | $793M | $713M | $776M | $741M | $653M | $1.01B | $851M | $581M | $526M | $486M | $185M | $197M | |
| Total Liabilities | $25.99B | $26.84B | $27.43B | $25.43B | $29.24B | $30.59B | $32.73B | $29.68B | $31.55B | $40.27B | $42.94B | $20.90B | |
| Long-term Debt | $20.82B | $21.62B | $22.39B | $20.77B | $22.65B | $23.93B | $25.89B | $24.30B | $25.44B | $29.85B | $31.09B | $15.23B | |
| Total Debt | $20.82B | $21.62B | $22.39B | $20.77B | $22.65B | $23.93B | $25.89B | $24.30B | $25.44B | $29.85B | $31.10B | $15.26B | |
| Common Stock | $10.52B | $10.49B | $10.42B | $10.39B | $10.32B | $10.23B | $10.17B | $10.12B | $10.09B | $10.04B | $9.90B | $8.35B | |
| Retained Earnings | $-9.67B | $-9.82B | $-9.78B | $-9.19B | $-8.96B | $-8.01B | $-7.45B | $-5.66B | $-2.73B | $-5.13B | $-2.75B | $-2.40B | |
| AOCI | $-1.76B | $-2.18B | $-1.88B | $-2.06B | $-1.92B | $-2.13B | $-2.09B | $-2.14B | $-1.90B | $-2.11B | $-1.54B | $-916M | |
| Stockholders' Equity | $-554M | $-1.28B | $-1.02B | $-692M | $-106M | $535M | $1.06B | $2.73B | $5.85B | $3.15B | $5.91B | $5.28B | |
| Liabilities + Equity | $26.37B | $26.52B | $27.35B | $25.69B | $29.20B | $31.20B | $33.86B | $32.49B | $37.50B | $43.53B | $48.97B | $26.30B | |
| Shares Outstanding | 370,531,987 | 367,843,058 | 365,238,917 | 361,898,846 | 359,405,748 | 355,422,347 | 352,562,636 | 349,871,102 | 348,708,567 | 347,821,606 | 342,926,531 | 334,402,964 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.21B | $1.27B | $1.26B | $1.39B | $1.55B | $1.82B | $2.08B | $2.82B | $2.86B | $2.87B | $2.47B | $1.61B | |
| Stock-based Comp | $216M | $150M | $132M | $126M | $128M | $105M | $102M | $87M | $87M | $165M | $140M | $78M | |
| Deferred Tax | $132M | $69M | $6M | $-188M | $-36M | $-599M | $-182M | $-337M | $-4.31B | $-268M | $56M | $23M | |
| Restructuring | · | · | · | · | · | $22M | $31M | $22M | $52M | $132M | $362M | $382M | |
| Operating Cash Flow | $1.40B | $1.60B | $1.03B | $-728M | $1.43B | $1.11B | $1.50B | $1.50B | $2.29B | $2.09B | $2.26B | $2.31B | |
| CapEx | $397M | $337M | $215M | $218M | $269M | $302M | $270M | $157M | $171M | $235M | $235M | $292M | |
| Investing Cash Flow | $-595M | $-454M | $-2.15B | $-303M | $409M | $-261M | $-419M | $-196M | $2.89B | $-125M | $-15.58B | $-100M | |
| Debt Issued | $10.55B | $661M | $3.29B | $6.84B | $2.10B | $3.46B | $5.96B | $8.94B | $9.42B | $1.22B | $17.82B | $1.63B | |
| Net Debt Issued | $-637M | $-799M | $1.58B | $-1.01B | $-1.34B | $-2.19B | $1.55B | $-1.16B | $-4.78B | $-1.22B | $15.76B | $-2.26B | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | $1.43B | $0 | |
| Stock Repurchased | · | · | · | · | · | · | · | · | $0 | $0 | $72M | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $0 | $0 | $1.36B | $0 | |
| Financing Cash Flow | $-742M | $-868M | $1.48B | $-474M | $-1.51B | $-2.29B | $1.44B | $-1.35B | $-4.96B | $-1.96B | $13.62B | $-2.46B | |
| Net Change in Cash | $124M | $239M | $371M | $-1.53B | $303M | $-1.43B | $2.52B | $-74M | $255M | $-55M | $274M | · | |
| Taxes Paid | $163M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.00B | $1.26B | $817M | $-946M | $1.16B | $809M | $1.23B | $1.34B | $2.12B | $1.85B | $1.97B | $2.00B |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 17.7% | 16.1% | 11.0% | 5.6% | 5.3% | 8.4% | -2.4% | -28.4% | 1.2% | -5.9% | 14.6% | 24.7% | |
| Net Margin | 1.5% | -0.48% | -6.8% | -2.8% | -11.2% | -7.0% | -20.7% | -49.5% | 27.6% | -24.9% | -2.8% | 11.0% | |
| Pretax Margin | 3.6% | 1.7% | -4.5% | -1.6% | -12.1% | -11.6% | -21.4% | -49.6% | -20.0% | -25.2% | -1.5% | 13.2% | |
| EBITDA Margin | 17.7% | 16.1% | 11.0% | 5.6% | 5.3% | 8.4% | -2.4% | -28.4% | 1.2% | -5.9% | 14.6% | 24.7% | |
| ROA | 0.59% | -0.17% | -2.2% | -0.82% | -3.1% | -1.7% | -5.4% | -11.8% | 5.9% | -5.2% | -0.76% | 3.4% | |
| ROE | -17.1% | 4.0% | 69.1% | 56.4% | -442.0% | -70.0% | -93.9% | -114.0% | 53.4% | -53.1% | -5.1% | 17.5% | |
| ROIC | 2.9% | -3.3% | 7.1% | 3.7% | 1.8% | 1.7% | -0.73% | -8.8% | -0.45% | -1.7% | 7.6% | 8.3% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 0.9 | 1.3 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 | 1.4 | 1.0 | 1.5 | |
| Quick Ratio | 0.9 | 0.5 | 0.7 | 0.6 | 0.5 | 0.4 | 0.8 | 0.7 | 0.7 | 0.8 | 0.6 | 0.9 | |
| Debt / Equity | -37.6 | -16.9 | -21.9 | -30.0 | -213.7 | 44.7 | 24.4 | 8.9 | 4.4 | 9.5 | 5.3 | 2.9 | |
| LT Debt / Equity | -37.2 | -14.8 | -21.5 | -29.4 | -213.7 | 44.7 | 23.2 | 8.8 | 4.3 | 9.5 | 5.1 | 2.9 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.3 | 0.3 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | 2.4 | 2.2 | 2.4 | 2.4 | |
| Receivables Turnover | 4.6 | 4.7 | 4.6 | 4.6 | 5.0 | 4.7 | 4.6 | 4.2 | 3.8 | 3.7 | 4.4 | 4.4 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.50 | $-3.48 | $-2.80 | $-1.91 | $-0.29 | $1.51 | $3.02 | $7.81 | $16.77 | $9.06 | $17.24 | $15.89 | |
| Revenue / Share | $27.38 | $26.15 | $24.00 | $22.44 | $23.50 | · | $24.43 | $23.85 | $24.80 | $27.85 | $30.48 | $24.20 | |
| Cash Flow / Share | $3.73 | $4.34 | $2.83 | $-2.01 | $3.97 | · | $4.26 | $4.27 | $6.51 | $6.01 | $6.42 | $6.72 | |
| Cash / Share | $3.53 | $3.21 | $2.59 | $1.56 | $1.62 | $1.70 | $9.20 | $2.06 | $2.06 | $1.56 | $1.74 | $0.96 | |
| EPS (TTM) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 | $-1.58 | $-5.08 | $-11.81 | $6.83 | $-6.94 | $-0.85 | $2.58 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.7% | 9.9% | 7.8% | -3.7% | 5.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 8.1% | 4.5% | 2.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.0% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10.27B | $9.62B | $8.76B | $8.12B | $8.43B | $8.03B | $8.60B | $8.38B | $8.72B | $9.67B | $10.45B | $8.21B | |
| Net Income TTM | $157M | $-46M | $-592M | $-225M | $-948M | $-560M | $-1.79B | $-4.14B | $2.40B | $-2.41B | $-288M | $880M | |
| Market Cap | $2.58B | $2.96B | $2.93B | $2.27B | $9.92B | $7.39B | $10.55B | $6.46B | $7.25B | $5.05B | $34.86B | $47.86B | |
| Enterprise Value | $22.08B | $23.40B | $24.37B | $22.47B | $32.00B | $30.71B | $33.20B | $30.05B | $31.97B | $34.36B | $65.37B | $62.79B | |
| P/E | 16.5 | -62.0 | -5.0 | -10.1 | -10.5 | -13.2 | -5.9 | -1.6 | 3.0 | -2.1 | -119.6 | 55.5 | |
| P/S | 0.3 | 0.3 | 0.3 | 0.3 | 1.2 | 0.9 | 1.2 | 0.8 | 0.8 | 0.5 | 3.3 | 5.8 | |
| P/B | -4.6 | -2.3 | -2.9 | -3.3 | -93.6 | 13.8 | 9.9 | 2.4 | 1.2 | 1.6 | 5.9 | 9.0 | |
| P / Cash Flow | 1.8 | 1.9 | 2.8 | -3.1 | 7.0 | 6.7 | 7.0 | 4.3 | 3.2 | 2.4 | 15.8 | 20.9 | |
| P / FCF | 2.6 | 2.4 | 3.6 | -2.4 | 8.6 | 9.1 | 8.6 | 4.8 | 3.4 | 2.7 | 17.7 | 23.9 | |
| EV / EBITDA | 12.2 | 15.1 | 25.3 | 49.5 | 71.1 | 45.4 | -163.6 | -12.6 | 313.4 | -60.7 | 42.8 | 30.8 | |
| EV / FCF | 22.0 | 18.6 | 29.8 | -23.8 | 27.7 | 38.0 | 27.0 | 22.4 | 15.1 | 18.6 | 33.3 | 31.3 | |
| EV / Revenue | 2.2 | 2.4 | 2.8 | 2.8 | 3.8 | 3.8 | 3.9 | 3.6 | 3.7 | 3.6 | 6.3 | 7.7 | |
| Earnings Yield | 6.0% | -1.6% | -20.2% | -9.9% | -9.6% | -7.6% | -17.0% | -63.9% | 32.9% | -47.8% | -0.84% | 1.8% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.85B | $2.52B | $2.80B | $2.68B | $2.53B | $2.26B | $2.56B | $2.51B | $2.40B | $2.15B | $2.41B | $2.24B | $2.17B | $1.94B | $2.19B | $2.05B | |
| SG&A Expense | $907M | $861M | $882M | $795M | $894M | $867M | $820M | $850M | $832M | $794M | $766M | $715M | $711M | $725M | $666M | $661M | |
| Operating Expenses | $2.11B | $3.47B | $2.32B | $2.06B | $2.09B | $1.98B | $2.00B | $2.19B | $2.01B | $1.87B | $2.05B | $2.22B | $1.75B | $1.77B | $2.43B | $1.80B | |
| Operating Income | $740M | $-950M | $474M | $619M | $444M | $276M | $558M | $318M | $389M | $281M | $362M | $14M | $412M | $175M | $-236M | $244M | |
| Interest Income | $11M | $10M | $9M | $15M | $13M | $11M | $9M | $7M | $8M | $9M | $7M | $6M | $7M | $6M | $6M | $3M | |
| Other Non-op | · | · | · | · | · | · | $-2M | $-225M | $-20M | $0 | $-28M | $-60M | $83M | $-23M | $-29M | $-4M | |
| Pretax Income | $348M | $-1.35B | $56M | $218M | $140M | $-47M | $209M | $-21M | $48M | $-69M | $-7M | $-326M | $79M | $-136M | $-357M | $439M | |
| Income Tax | $88M | $77M | $159M | $37M | $12M | $39M | $111M | $71M | $49M | $8M | $40M | $56M | $52M | $73M | $53M | $36M | |
| Net Income | $258M | $-1.42B | $-112M | $179M | $148M | $-58M | $93M | $-85M | $10M | $-64M | $-39M | $-378M | $26M | $-201M | $-410M | $399M | |
| EPS (Basic) | $0.69 | $-3.82 | $-0.30 | $0.48 | $0.40 | $-0.16 | $0.24 | $-0.23 | $0.03 | $-0.17 | $-0.11 | $-1.03 | $0.07 | $-0.55 | $-1.13 | $1.10 | |
| EPS (Diluted) | $0.68 | $-3.82 | $-0.30 | $0.48 | $0.40 | $-0.16 | $0.24 | $-0.23 | $0.03 | $-0.17 | $-0.11 | $-1.03 | $0.07 | $-0.55 | $-1.13 | $1.10 | |
| Shares (Basic) | 375,000,000 | 372,800,000 | · | 371,300,000 | 370,900,000 | 369,600,000 | · | 368,400,000 | 367,900,000 | 366,800,000 | · | 365,400,000 | 364,800,000 | 363,300,000 | · | 362,500,000 | |
| Shares (Diluted) | 378,100,000 | 372,800,000 | · | 375,500,000 | 373,100,000 | 369,600,000 | · | 368,400,000 | 370,200,000 | 366,800,000 | · | 365,400,000 | 367,100,000 | 363,300,000 | · | 363,400,000 | |
| EBITDA | $740M | $-950M | · | $619M | $444M | $276M | · | $318M | $389M | $281M | · | $14M | $412M | $175M | · | $244M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.82B | $1.30B | $1.31B | $1.31B | $1.73B | $1.13B | $1.18B | $719M | $595M | $733M | $947M | $760M | $579M | $518M | $564M | $486M | |
| Receivables | $2.26B | $2.19B | $2.35B | $2.42B | $2.21B | $2.07B | $2.14B | $2.09B | $2.10B | $2.05B | · | $1.95B | $1.74B | $1.69B | · | $1.74B | |
| Inventory | $1.60B | $1.60B | $1.63B | $1.60B | $1.66B | $1.61B | $1.59B | $1.66B | $1.61B | $1.64B | · | $1.27B | $1.24B | $1.22B | · | $1.06B | |
| Prepaid Expense | $819M | $874M | $852M | $894M | $906M | $890M | $838M | $852M | $874M | $957M | · | $1.05B | $890M | $796M | · | $718M | |
| Current Assets | $6.52B | $5.98B | $6.16B | $6.25B | $6.51B | $5.73B | $5.77B | $5.35B | $5.21B | $5.40B | · | $5.05B | $4.46B | $4.24B | · | $4.01B | |
| PP&E (Net) | · | · | $2.07B | $2.03B | $1.99B | $1.88B | $1.78B | $1.79B | $1.74B | $1.71B | · | $1.58B | $1.60B | $1.60B | · | $1.51B | |
| PP&E (Gross) | · | · | $4.50B | · | · | · | $3.92B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $2.42B | · | · | · | $2.14B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $9.79B | $9.81B | $11.27B | $11.29B | $11.30B | $11.15B | $11.09B | $11.17B | $11.13B | $11.16B | $11.18B | $11.19B | $11.63B | $11.58B | $11.55B | $12.04B | |
| Intangibles | $4.18B | $4.40B | $4.64B | $4.83B | $5.05B | $5.30B | $5.55B | $5.65B | $5.90B | $6.18B | · | $6.73B | $5.30B | $5.55B | · | $6.02B | |
| Other Non-current Assets | $358M | $369M | $378M | $382M | $388M | $380M | $363M | $389M | $329M | $312M | · | $328M | $325M | $318M | · | $341M | |
| Total Assets | $24.79B | $24.50B | $26.37B | $26.82B | $27.27B | $26.42B | $26.52B | $26.54B | $26.50B | $26.91B | · | $27.06B | $25.50B | $25.45B | · | $26.30B | |
| Accounts Payable | $593M | $593M | $600M | $616M | $627M | $620M | $589M | $667M | $579M | $642M | · | $569M | $515M | $561M | · | $486M | |
| Accrued Liabilities | $3.07B | $3.04B | $3.34B | $3.60B | $3.47B | $3.35B | $3.49B | $3.39B | $3.34B | $3.23B | · | $3.12B | $3.01B | $2.92B | · | $2.93B | |
| Current Liabilities | $4.54B | $4.53B | $4.18B | $4.79B | $4.97B | $4.26B | $6.75B | $4.51B | $4.37B | $4.41B | · | $4.22B | $3.97B | $3.92B | · | $3.83B | |
| Capital Leases | · | · | $167M | · | · | · | $165M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $211M | $179M | $147M | $145M | $144M | $134M | $128M | $169M | $170M | $170M | · | $213M | $215M | $205M | · | $422M | |
| Other Non-current Liabilities | $733M | $763M | $793M | $843M | $877M | $761M | $713M | $805M | $745M | $751M | · | $721M | $745M | $746M | · | $619M | |
| Total Liabilities | $25.60B | $25.58B | $25.99B | $26.47B | $27.12B | $26.66B | $26.84B | $26.78B | $26.72B | $27.09B | · | $27.30B | $25.23B | $25.30B | · | $25.86B | |
| Long-term Debt | $20.74B | $20.76B | $20.82B | $21.04B | $21.74B | $21.51B | $21.62B | $21.51B | $21.66B | $22.07B | · | $22.43B | $20.55B | $20.65B | · | $21.21B | |
| Total Debt | $20.74B | $20.76B | · | $21.04B | $21.74B | $21.51B | · | $21.51B | $21.66B | $22.07B | · | $22.43B | $20.55B | $20.65B | · | $21.21B | |
| Common Stock | $10.54B | $10.54B | $10.52B | $10.52B | $10.51B | $10.51B | $10.49B | $10.49B | $10.48B | $10.48B | · | $10.42B | $10.41B | $10.40B | · | $10.39B | |
| Retained Earnings | $-10.83B | $-11.09B | $-9.67B | $-9.55B | $-9.73B | $-9.88B | $-9.82B | $-9.92B | $-9.83B | $-9.84B | · | $-9.74B | $-9.36B | $-9.39B | · | $-8.78B | |
| AOCI | $-1.82B | $-1.81B | $-1.76B | $-1.80B | $-1.79B | $-2.03B | $-2.18B | $-1.95B | $-2.01B | $-1.92B | · | $-2.05B | $-1.90B | $-1.99B | · | $-2.27B | |
| Stockholders' Equity | $-1.77B | $-2.06B | $-554M | $-565M | $-764M | $-1.18B | $-1.28B | $-1.17B | $-1.18B | $-1.11B | · | $-1.18B | $-663M | $-800M | · | $-525M | |
| Liabilities + Equity | $24.79B | $24.50B | $26.37B | $26.82B | $27.27B | $26.42B | $26.52B | $26.54B | $26.50B | $26.91B | · | $27.06B | $25.50B | $25.45B | · | $26.30B | |
| Shares Outstanding | 373,901,440 | 373,464,760 | 370,531,987 | 370,473,221 | 369,749,489 | 369,539,455 | 367,843,058 | 367,695,267 | 366,985,967 | 366,674,264 | · | 365,043,317 | 364,063,514 | 363,607,062 | · | 361,781,292 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $281M | $295M | $290M | $306M | $307M | $305M | $307M | $322M | $318M | $320M | $329M | $301M | $315M | $319M | $360M | $335M | |
| Stock-based Comp | $54M | $52M | $84M | $43M | $46M | $43M | $43M | $38M | $36M | $33M | $29M | $29M | $33M | $41M | $35M | $33M | |
| Operating Cash Flow | $670M | $230M | $495M | $405M | $289M | $211M | $601M | $405M | $380M | $211M | $390M | $282M | $206M | $154M | $475M | $-1.26B | |
| CapEx | $77M | $109M | $92M | $91M | $99M | $115M | $106M | $71M | $78M | $82M | $98M | $42M | $28M | $47M | $66M | $54M | |
| Investing Cash Flow | $-93M | $-139M | $-282M | $-83M | $-100M | $-130M | $-200M | $-102M | $-79M | $-73M | $-148M | $-1.89B | $-30M | $-78M | $-136M | $-53M | |
| Debt Issued | $84M | $2.80B | $133M | $-1M | $10.37B | $50M | $506M | $0 | $80M | $75M | $146M | $2.69B | $300M | $155M | $355M | $161M | |
| Net Debt Issued | · | $-55M | · | · | · | $-118M | · | · | · | $-315M | · | · | · | $-124M | · | · | |
| Financing Cash Flow | $-49M | $-100M | $-235M | $-719M | $358M | $-146M | $85M | $-189M | $-424M | $-340M | $-79M | $1.82B | $-120M | $-142M | $-276M | $-36M | |
| Net Change in Cash | $526M | $-13M | $-15M | $-403M | $586M | $-44M | $451M | $127M | $-132M | $-207M | $182M | $192M | $57M | $-60M | $94M | $-1.38B | |
| Free Cash Flow | · | $121M | · | · | · | $96M | · | · | · | $129M | · | · | · | $107M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 25.9% | -37.6% | · | 23.1% | 17.5% | 12.2% | · | 12.7% | 16.2% | 13.1% | · | 0.63% | 19.0% | 9.0% | · | 11.9% | |
| Net Margin | 9.0% | -56.4% | · | 6.7% | 5.9% | -2.6% | · | -3.4% | 0.42% | -3.0% | · | -16.9% | 1.2% | -10.3% | · | 19.5% | |
| Pretax Margin | 12.2% | -53.6% | · | 8.1% | 5.5% | -2.1% | · | -0.84% | 2.0% | -3.2% | · | -14.6% | 3.6% | -7.0% | · | 21.5% | |
| EBITDA Margin | 25.9% | -37.6% | · | 23.1% | 17.5% | 12.2% | · | 12.7% | 16.2% | 13.1% | · | 0.63% | 19.0% | 9.0% | · | 11.9% | |
| ROA | 0.99% | -5.6% | · | 0.67% | 0.55% | -0.22% | · | -0.32% | 0.04% | -0.24% | · | -1.4% | 0.10% | -0.74% | · | 1.4% | |
| ROE | -20.4% | 87.8% | · | -20.6% | -15.3% | 5.1% | · | 7.2% | -1.1% | 6.7% | · | 44.3% | -3.8% | 39.6% | · | -109.5% | |
| ROIC | 2.9% | -5.4% | · | 2.5% | 1.9% | 2.5% | · | 6.9% | -0.04% | 1.5% | · | 0.08% | 0.71% | 1.4% | · | 1.1% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.3 | · | 1.3 | 1.3 | 1.3 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.1 | 1.1 | · | 1.0 | |
| Quick Ratio | 0.9 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | -11.7 | -10.1 | · | -37.2 | -28.5 | -18.2 | · | -18.3 | -18.4 | -19.8 | · | -19.0 | -31.0 | -25.8 | · | -40.4 | |
| LT Debt / Equity | -11.2 | -9.7 | · | -36.2 | -27.3 | -17.9 | · | -17.9 | -18.0 | -19.3 | · | -18.6 | -30.3 | -25.3 | · | -39.6 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.3 | 1.2 | · | 1.2 | 1.2 | 1.1 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.3 | 1.2 | · | 1.2 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-4.74 | $-5.51 | · | $-1.53 | $-2.07 | $-3.20 | · | $-3.19 | $-3.20 | $-3.04 | · | $-3.23 | $-1.82 | $-2.20 | · | $-1.45 | |
| Revenue / Share | $7.54 | $6.77 | · | $7.14 | $6.78 | $6.11 | · | $6.81 | $6.49 | $5.87 | · | $6.12 | $5.90 | $5.35 | · | $5.63 | |
| Cash Flow / Share | · | $0.62 | · | · | · | $0.57 | · | · | · | $0.58 | · | · | · | $0.42 | · | · | |
| Cash / Share | $4.88 | $3.48 | · | $3.53 | $4.67 | $3.07 | · | $1.96 | $1.62 | $2.00 | · | $2.08 | $1.59 | $1.42 | · | $1.34 | |
| EPS (TTM) | $-2.96 | $-3.24 | · | $0.96 | $0.25 | $-0.12 | · | $-0.48 | $-1.28 | $-1.24 | · | $-2.64 | $-0.51 | $-0.98 | · | $0.72 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $10.85B | $10.53B | · | $10.03B | $9.86B | $9.73B | · | $9.47B | $9.20B | $8.97B | · | $8.54B | $8.35B | $8.15B | · | $8.13B | |
| Net Income TTM | $-1.10B | $-1.21B | · | $362M | $98M | $-40M | · | $-178M | $-471M | $-455M | · | $-963M | $-186M | $-357M | · | $254M | |
| Market Cap | $1.84B | $2.02B | · | $2.39B | $2.46B | $2.39B | · | $3.00B | $2.56B | $3.89B | · | $3.00B | $2.91B | $2.95B | · | $2.49B | |
| Enterprise Value | $20.76B | $21.48B | · | $22.12B | $22.47B | $22.77B | · | $23.79B | $23.62B | $25.23B | · | $24.67B | $22.89B | $23.08B | · | $23.22B | |
| P/E | -1.7 | -1.7 | · | 6.7 | 26.6 | -53.9 | · | -17.0 | -5.4 | -8.6 | · | -3.1 | -15.7 | -8.3 | · | 9.6 | |
| P/S | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.3 | 0.4 | · | 0.3 | |
| P/B | -1.0 | -1.0 | · | -4.2 | -3.2 | -2.0 | · | -2.6 | -2.2 | -3.5 | · | -2.5 | -4.4 | -3.7 | · | -4.7 | |
| P / Cash Flow | · | 8.8 | · | · | · | 11.3 | · | · | · | 18.4 | · | · | · | 19.1 | · | · | |
| EV / Revenue | 1.9 | 2.0 | · | 2.2 | 2.3 | 2.3 | · | 2.5 | 2.6 | 2.8 | · | 2.9 | 2.7 | 2.8 | · | 2.9 | |
| Earnings Yield | -60.0% | -60.0% | · | 14.9% | 3.8% | -1.8% | · | -5.9% | -18.4% | -11.7% | · | -32.1% | -6.4% | -12.1% | · | 10.4% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $10.27B | $9.62B | $8.76B | $8.12B | $8.43B |
| Betriebsgewinnmarge % | 17.7% | 16.1% | 11.0% | 5.6% | 5.3% |
| Nettoergebnis | $157M | $-46M | $-592M | $-225M | $-948M |
| Verwässerte EPS | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | -37.6 | -16.9 | -21.9 | -30.0 | -213.7 |
| Liquiditätsgrad | 1.5 | 0.9 | 1.3 | 1.1 | 1.1 |
| Quick Ratio | 0.9 | 0.5 | 0.7 | 0.6 | 0.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $1.00B | $1.26B | $817M | $-946M | $1.16B |
Institutionelle Eigentümer (13F) 262 Einreicher · $1.3B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
262
Gehaltener Wert
$1.3B
Neue Positionen
28
Geschlossene Positionen
30
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 28 (-5 vs. Vorquartal) | 30 (0 vs. Vorquartal) | 78 (-11 vs. Vorquartal) | 72 (+6 vs. Vorquartal) | +11.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| PAULSON & CO. INC. | $361.151.434 | 73.255.869 | 28,47% | Aktien |
| GOLDENTREE ASSET MANAGEMENT LP | $170.706.865 | 34.665.731 | 13,46% | Aktien |
| VANGUARD GROUP INC | $74.149.574 | 10.679.760 | 5,85% | Aktien |
| ROYAL BANK OF CANADA | $53.404.000 | 10.832.582 | 4,21% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $39.440.000 | 8.000.000 | 3,11% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $36.797.292 | 7.465.468 | 2,90% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $33.169.671 | 4.803.485 | 2,61% | Aktien |
| GOLDMAN SACHS GROUP INC | $30.689.896 | 6.225.131 | 2,42% | Aktien |
| MFN Partners Management, LP | $29.580.000 | 6.000.000 | 2,33% | Aktien |
| Kohlberg Kravis Roberts & Co. L.P. | $25.808.550 | 5.235.000 | 2,03% | Aktien |
| ING GROEP NV | $24.650.000 | 5.000.000 | 1,94% | Aktien |
| Hudson Bay Capital Management LP | $24.650.000 | 5.000.000 | 1,94% | Aktien |
| GENDELL JEFFREY L | $19.902.859 | 4.037.091 | 1,57% | Aktien |
| Lombard Odier Asset Management (USA) Corp | $19.720.000 | 4.000.000 | 1,55% | Verkaufsoption |
| NORGES BANK | $16.914.543 | 3.431.117 | 1,33% | Aktien |
| MACQUARIE GROUP LTD | $16.022.500 | 3.250.000 | 1,26% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $15.976.544 | 3.241.140 | 1,26% | Aktien |
| D. E. Shaw & Co., Inc. | $13.258.130 | 2.689.942 | 1,05% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $11.094.735 | 2.250.910 | 0,87% | Aktien |
| Point72 Asset Management, L.P. | $11.021.637 | 2.235.821 | 0,87% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10.771.345 | 2.186.244 | 0,85% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $10.528.419 | 2.135.582 | 0,83% | Aktien |
| PRIVATE MANAGEMENT GROUP INC | $8.301.316 | 1.683.837 | 0,65% | Aktien |
| Qube Research & Technologies Ltd | $8.291.856 | 1.681.918 | 0,65% | Aktien |
| BARCLAYS PLC | $8.134.500 | 1.650.000 | 0,64% | Verkaufsoption |
| TWO SIGMA ADVISERS, LP | $7.366.576 | 1.059.939 | 0,58% | Aktien |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $7.365.406 | 1.494.205 | 0,58% | Aktien |
| Man Group plc | $7.157.280 | 1.451.781 | 0,56% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.903.479 | 1.400.300 | 0,54% | Verkaufsoption |
| RENAISSANCE TECHNOLOGIES LLC | $6.530.027 | 1.324.549 | 0,51% | Aktien |
| MORGAN STANLEY | $6.174.733 | 1.252.481 | 0,49% | Aktien |
| CITADEL ADVISORS LLC | $5.447.922 | 1.105.055 | 0,43% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $5.394.096 | 1.095.104 | 0,43% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.138.046 | 1.042.200 | 0,41% | Kaufoption |
| DEUTSCHE BANK AG\ | $4.930.000 | 1.000.000 | 0,39% | Kaufoption |
| BANK OF MONTREAL /CAN/ | $4.856.469 | 986.351 | 0,38% | Aktien |
| TD Asset Management Inc | $4.624.904 | 938.710 | 0,36% | Aktien |
| SIG North Trading, ULC | $4.360.585 | 884.500 | 0,34% | Kaufoption |
| JPMORGAN CHASE & CO | $4.272.070 | 880.839 | 0,34% | Aktien |
| Bridgewater Associates, LP | $4.270.785 | 866.285 | 0,34% | Aktien |
| Vanguard Global Advisers, LLC | $4.217.745 | 855.700 | 0,33% | Aktien |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $3.712.320 | 753.006 | 0,29% | Aktien |
| UBS Group AG | $3.668.940 | 744.207 | 0,29% | Aktien |
| CITADEL ADVISORS LLC | $3.660.525 | 742.500 | 0,29% | Verkaufsoption |
| GAMCO INVESTORS, INC. ET AL | $3.486.772 | 707.256 | 0,27% | Aktien |
| WHITEBOX ADVISORS LLC | $3.030.333 | 614.672 | 0,24% | Aktien |
| Jump Financial, LLC | $3.012.723 | 611.100 | 0,24% | Aktien |
| TORONTO DOMINION BANK | $2.916.546 | 592.351 | 0,23% | Aktien |
| BANK OF AMERICA CORP /DE/ | $2.815.928 | 571.182 | 0,22% | Aktien |
| WOLVERINE ASSET MANAGEMENT LLC | $2.680.441 | 543.700 | 0,21% | Verkaufsoption |
Aktivisten & 5%+-Eigentümer 28 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Icahn Partners Master Fund LP, Icahn Offshore LP, Icahn Partners LP, Icahn Onshore LP, Icahn Capital LP, IPH GP LLC, Icahn Enterprises Holdings L.P., Icahn Enterprises G.P. Inc., Beckton Corp., Carl C. Icahn ×6 Einreichungen | 15. August 2025 | 0,00% | Änderung | · | SEC |
| PAULSON & CO. INC. ×6 Einreichungen | 14. August 2025 | 19,10% | Änderung | · | SEC |
| Alex Meruelo | 7. April 2025 | 9,99% | Erste Einreichung | Passive Anlage | SEC |
| 19. August 2024 | · | Erste Einreichung | · | SEC | |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 13. Mai 2022 | · | Erste Einreichung | · | SEC |
| Glenview Capital Management, LLC, Larry Robbins ×2 Einreichungen | 13. Dezember 2021 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 21. Juni 2021 | · | Erste Einreichung | Vorstandskampagne | SEC |
| 24. Februar 2021 | · | Erste Einreichung | · | SEC | |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 16. März 2017 | · | Erste Einreichung | Passive Anlage | SEC |
| Pershing Square Capital Management, L.P., PS Management GP, LLC, William A. Ackman ×12 Einreichungen | 14. März 2017 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 15. Juni 2015 | · | Erste Einreichung | · | SEC |
| Valeant Pharmaceuticals International, Inc., Valeant Pharmaceuticals International ×10 Einreichungen | 20. November 2014 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 25. September 2014 | · | Erste Einreichung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 8. Mai 2014 | · | Erste Einreichung | Vorstandskampagne | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 23. Mai 2012 | · | Erste Einreichung | Passive Anlage | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 23. Mai 2011 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 11. Mai 2011 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 1. März 2011 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 6. Oktober 2010 | · | Erste Einreichung | M&A / Verkauf | SEC |
| Nicht offengelegter meldender Beteiligter | 29. Juni 2010 | · | Erste Einreichung | M&A / Verkauf | SEC |
| Eugene Melnyk ×3 Einreichungen | 22. März 2010 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 23. Januar 2004 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 10. November 2003 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 19. August 2003 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 12. Dezember 2002 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 8. Mai 2002 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 15. Januar 2002 | · | Erste Einreichung | · | SEC |
| Nicht offengelegter meldender Beteiligter | 28. September 2001 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 79 Insider · 37 Führungskräfte · 41 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Thomas Appio | Chief Executive Officer | 2. März 2026 J | 2.315.374 | 0 | 0 | $0 |
| Howard Bradley Schiller | Chairman and CEO | 18. Februar 2016 F | 336.784 | 0 | 0 | $0 |
| Michael J. Pearson | Chief Executive Officer | 31. Dezember 2015 F | 1.514.664 | 0 | 0 | $0 |
| Jean-Jacques Charhon | EVP, CFO | 27. Februar 2026 F | 706.478 | 0 | 0 | $0 |
| Tom George Vadaketh | EVP, Chief Financial Officer | 5. September 2023 F | 564.933 | 0 | 0 | $0 |
| Sam Eldessouky | EVP & Chief Financial Officer | 3. März 2022 F | 119.455 | 0 | 0 | $0 |
| Philip Walden Loberg Jr | EVP, Interim CFO | 25. Juli 2011 A | 145.065 | 0 | 0 | $0 |
| Margaret Jean Mulligan | EVP, CFO | 11. November 2010 A | 83.014 | 0 | 0 | $0 |
| Aimee J. Lenar | President, US Pharma | 19. August 2026 S | 334.853 | 0 | 1 | $-258.894 |
| Robert Spurr | President, U.S. Businesses | 10. Mai 2022 M | 112.741 | 0 | 0 | $0 |
| William D. Humphries | President, Ortho-Dermatologics | 4. Dezember 2020 M | 235.035 | 0 | 0 | $0 |
| Mark C. Mckenna | President, Salix | 19. August 2019 S | 20.756 | 0 | 0 | $0 |
| Rajiv De Silva | President and COO | 5. Januar 2013 F | 259.767 | 0 | 0 | $0 |
| Richard Kevin Masterson | Pres. & COO, Valeant Intl. BB | 10. Mai 2012 S | 89.524 | 0 | 0 | $0 |
| Michel Chouinard | COO, Biovail Labs. Intl SRL | 22. Dezember 2010 A | 2.470 | 0 | 0 | $0 |
| Gilbert Godin | EVP & COO | 5. Juli 2010 A | · | 0 | 0 | $0 |
| Steven Hyosig Lee | SVP, Controller & CAO | 14. Juli 2026 F | 70.114 | 0 | 0 | $0 |
| Seana Carson | EVP, General Counsel | 3. März 2026 S | 616.761 | 0 | 3 | $-115.040 |
| John S Barresi | SVP, Controller & CAO | 28. Februar 2025 F | 192.268 | 0 | 0 | $0 |
| Frederick Munsch | SVP, Controller and CAO | 3. Mai 2022 F | 22.435 | 0 | 0 | $0 |
| Christina Ackermann | EVP AND GENERAL COUNSEL | 10. März 2022 F | 162.240 | 0 | 0 | $0 |
| Joseph F Gordon | Pres&Co-Head Bausch&Lomb/Int'l | 8. März 2022 S | 93.139 | 0 | 0 | $0 |
| Robert L. Rosiello | EVP, Corp Dev & Strategy | 5. Dezember 2016 F | 517.683 | 0 | 0 | $0 |
| Ari Kellen | EVP, Company Group Chairman | 5. Dezember 2016 F | 630.842 | 0 | 0 | $0 |
| Anne Clem Whitaker | EVP, Company Group Chairman | 5. Dezember 2016 F | 158.544 | 0 | 0 | $0 |
| Robert Roswell Chai-Onn | EVP, CLO, General Counsel | 12. Mai 2016 A | 124.815 | 0 | 0 | $0 |
| Debora Jorn | EVP, Company Group Chairman | 20. November 2015 F | 34.812 | 0 | 0 | $0 |
| Pavel Mirovsky | EVP, Pres. & GM Valeant EMENA | 23. Juni 2015 A | 69.525 | 0 | 0 | $0 |
| Brian M. Stolz | EVP, Administration & CHCO | 22. Juni 2015 F | 125.280 | 0 | 0 | $0 |
| Laizer Kornwasser | EVP, Company Group Chairman | 27. April 2015 D | 98.824 | 0 | 0 | $0 |
| Daniel Mark Wechsler | EVO, Co. Grp. Chmn, Eye Health | 12. August 2013 A | · | 0 | 0 | $0 |
| Susan Hall | Global Head of R&D | 26. Juli 2013 M | 27.588 | 0 | 0 | $0 |
| Jason David Hanson | EVP, Company Group Chairman | 11. Dezember 2012 A | · | 0 | 0 | $0 |
| Mark Andrew Durham | SVP Human Resources | 11. Mai 2011 M | 61.595 | 0 | 0 | $0 |
| Christine Mayer | SVP, BTA Pharmaceuticals, Inc. | 4. Oktober 2010 A | 0 | 0 | 0 | $0 |
| Hans Christian Fibiger | Chief Scientific Officer | 4. Oktober 2010 A | 0 | 0 | 0 | $0 |
| Gregory David Gubitz | SVP, Corp. Devel. & GC | 5. Juli 2010 A | · | 0 | 0 | $0 |
| Amy B Wechsler | Direktor | 30. September 2026 A | 316.158 | 0 | 0 | $0 |
| John Paulson | Direktor | 30. September 2026 A | 440.962 | 0 | 0 | $0 |
| Sandra Leung | Direktor | 30. September 2026 A | 102.859 | 0 | 0 | $0 |
| Frank D. Lee | Direktor | 22. Mai 2026 A | 95.210 | 0 | 1 | $-132.796 |
| Michael Goettler | Direktor | 22. Mai 2026 A | 76.020 | 0 | 0 | $0 |
| Eiry Roberts | Direktor | 22. Mai 2026 A | 45.871 | 0 | 0 | $0 |
| Sarah B Kavanagh | Direktor | 22. Mai 2026 A | 282.230 | 0 | 0 | $0 |
| Christian A Garcia | Direktor | 22. Mai 2026 A | 135.578 | 0 | 0 | $0 |
| Robert N Power | Direktor | 22. Mai 2026 A | 300.594 | 0 | 0 | $0 |
| Brett Icahn | Direktor | 30. Juni 2025 A | 220.280 | 0 | 0 | $0 |
| Steven D Miller | Direktor | 16. Mai 2025 A | 229.224 | 0 | 0 | $0 |
| Richard Mulligan | Direktor | 16. Mai 2025 A | 155.616 | 0 | 0 | $0 |
| Russel C Robertson | Direktor | 29. März 2024 A | 225.279 | 0 | 0 | $0 |
| Thomas W. Ross Sr. | Direktor | 19. Mai 2023 A | 161.516 | 0 | 0 | $0 |
| Richard U De Schutter | Direktor | 31. März 2023 A | 373.407 | 0 | 0 | $0 |
| Argeris N Karabelas | Direktor | 24. Juni 2022 A | 123.715 | 0 | 0 | $0 |
| Joseph C Papa | Direktor | 10. Mai 2022 M | 1.427.568 | 0 | 0 | $0 |
| Fredric N Eshelman | Direktor | 5. Mai 2017 A | 38.298 | 0 | 0 | $0 |
| Robert Alexander Ingram | Direktor | 31. März 2017 A | 92.046 | 0 | 0 | $0 |
| Ronald Harold Farmer | Direktor | 2. Mai 2016 A | 38.447 | 0 | 0 | $0 |
| Norma Ann Provencio | Direktor | 2. Mai 2016 A | 144.899 | 0 | 0 | $0 |
| Kyriazi Theo Melas | Direktor | 2. Mai 2016 A | 223.087 | 0 | 0 | $0 |
| Anders Lonner | Direktor | 26. Mai 2015 F | 29.891 | 0 | 0 | $0 |
| Katharine Berghuis Stevenson | Direktor | 22. Mai 2015 A | 24.705 | 0 | 0 | $0 |
| Colleen A Goggins | Direktor | 22. Mai 2015 A | 4.973 | 0 | 0 | $0 |
| Fred Hassan | Direktor | 29. August 2013 P | 53.969 | 0 | 0 | $0 |
| Lloyd Mitchell Segal | Direktor | 14. Juni 2013 P | 21.174 | 0 | 0 | $0 |
| Mason G Morfit | Direktor | 4. Juni 2012 A | 81.106 | 0 | 0 | $0 |
| Laurence E Paul | Direktor | 1. Juni 2012 P | 60.459 | 0 | 0 | $0 |
| Michael Robert Van Every | Direktor | 19. Mai 2011 A | 6.397 | 0 | 0 | $0 |
| William Mcdowall Wells | Direktor | 7. Dezember 2010 M | 75.000 | 0 | 0 | $0 |
| Louis Randall Tull | Direktor | 5. Juli 2010 A | · | 0 | 0 | $0 |
| Douglas John Paul Squires | Direktor | 5. Juli 2010 A | 29.688 | 0 | 0 | $0 |
| John Spencer Lanthier | Direktor | 5. Juli 2010 A | · | 0 | 0 | $0 |
| Frank Potter | Direktor | 5. Juli 2010 A | · | 0 | 0 | $0 |
| David H. Laidley | Direktor | 5. Juli 2010 A | · | 0 | 0 | $0 |
| Mark W Parrish | Direktor | 5. Juli 2010 A | · | 0 | 0 | $0 |
| GOUIN SERGE | Direktor | 5. Juli 2010 A | · | 0 | 0 | $0 |
| PAULSON & CO. INC. | 10%-Eigentümer | 25. November 2025 P | 73.255.869 | 1 | 0 | $15.625.000 |
| Andrew C. Von Eschenbach | · | 5. August 2021 P | 38.647 | 0 | 0 | $0 |
| Paul Herendeen | · | 8. März 2021 M | 386.618 | 0 | 0 | $0 |
| Ryan Weldon | · | 28. April 2014 M | 103.409 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 18 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| TLTD · FlexShares Trust | 0,08% | 78.045 NS | 31. Juli 2026 | N-PORT |
| ISCF · iShares Trust | 0,07% | 79.984 SH | 11. September 2026 | Täglich |
| DFIS · Dimensional ETF Trust | 0,04% | 336.568 NS | 31. Juli 2026 | N-PORT |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 978.582 SH | 19. August 2026 | Täglich |
| DISV · Dimensional ETF Trust | 0,03% | 214.485 NS | 31. Juli 2026 | N-PORT |
| DXIV · Dimensional ETF Trust | 0,03% | 7.943 NS | 31. Juli 2026 | N-PORT |
| PXF · Invesco Exchange-Traded Fund Trust … | 0,02% | 120.464 SH | 1. Oktober 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 16.543 SH | 10. September 2026 | Täglich |
| DFSI · Dimensional ETF Trust | 0,01% | 23.138 NS | 31. Juli 2026 | N-PORT |
| DFIC · Dimensional ETF Trust | 0,01% | 234.253 NS | 31. Juli 2026 | N-PORT |
| DFAX · Dimensional ETF Trust | 0,01% | 120.510 NS | 31. Juli 2026 | N-PORT |
| IDEV · iShares Trust | 0,01% | 364.677 SH | 11. September 2026 | Täglich |
| IXUS · iShares Trust | 0,00% | 379.290 SH | 11. September 2026 | Täglich |
| DFAI · Dimensional ETF Trust | 0,00% | 88.488 NS | 31. Juli 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 3.762.192 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 190.882 SH | 19. August 2026 | Täglich |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 2.481.313 SH | 19. August 2026 | Täglich |
| VSGX · VANGUARD WORLD FUND | 0,00% | 52.499 SH | 19. August 2026 | Täglich |
BHC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 8 Analysten
VERKAUF
Median-Ziel
$7.00
+20,7%
0 0,0%
Starker Kauf
0 0,0%
Kauf
4 50,0%
Halten
3 37,5%
Verkauf
1 12,5%
Starker Verkauf
12-Monats-Kursziel
5 Analysten · 2026-10-03Mittelwert-Ziel $7.50 +29,3%
← Unter allen Zielen
Aktueller Preis $5.80
Tief$6.50
Mittelwert$7.50
Hoch$9.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| BHC | $2.58B | 16.5 | 6.7% | 1.5% | -17.1% | · |
| TLRY | $726M | -5.1 | 11.5% | -13.3% | -7.8% | 28.4% |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Jul 30, 2026